#WCLC #WorldConferenceonLungCancer #Nonsmallcelllungcancer #NSCLC #smallcelllungcancer #SCLC #BioNTech #OncoC4 #Akeso #SummitTherapeutics #Roche #MediLink #Oncology #antiCTLA4immunotherapy #PRESERVE003trial #squamousnonsmallcelllungcancer #PD1xVEGFbispecificantibody #NSCLCtreatment
zurl.co/CdfXl
zurl.co/CdfXl
WCLC: Lung cancer news from BioNTech, Akeso, and Roche
As the World Conference on Lung Cancer (WCLC) draws to a close, here are some late-breaking clinical trial data that made waves at the congress.
zurl.co
September 18, 2026 at 10:39 AM
As the #WorldConferenceonLungCancer (WCLC) draws to a close, here is some of the late-breaking #clinicaltrialdata that made waves at the congress.
pharmaphorum.com/news/wclc-lu...
pharmaphorum.com/news/wclc-lu...
September 15, 2026 at 9:37 AM
As the #WorldConferenceonLungCancer (WCLC) draws to a close, here is some of the late-breaking #clinicaltrialdata that made waves at the congress.
pharmaphorum.com/news/wclc-lu...
pharmaphorum.com/news/wclc-lu...